non alcoholic hepatic steatosis - Sports Zone
EurekAlert!: Interferon regulatory factor 8 drives hepatic steatosis via PPARγ: a potential target for non-alcoholic fatty liver disease treatment Interferon regulatory factor 8 drives hepatic steatosis via PPARγ: a potential target for non-alcoholic fatty liver disease treatment News Medical: Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause of liver disease, affecting 4.7% of U.S. adults, non-alcoholic fatty liver ...
Understanding the Context
Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to ... EurekAlert!: The role of solute carrier family transporters in hepatic steatosis and hepatic fibrosis The role of solute carrier family transporters in hepatic steatosis and hepatic fibrosis